Report
Oliver Metzger

Amplifon : Q3 review – Slower market growth reflected in estimates

>Q3 review – Bottom line below expectations - Amplifon's Q3 revenues of € 567.6m (+6.8% y-o-y, 2%/0% vs expectations) was supported by an organic growth of 4.3%, external growth of 370bp and impacted by a forex headwind of 190bp. While Americas and APAC showed strong organic growth of 13.5% and 6.0%, respectively, the most important region Europe was up by just 1.2% organically. On the bottom line, Amplifon reported a recurring EBITDA of € 115.0m (+4.9% y-o-y, ma...
Underlying
Amplifon S.p.A.

Amplifon is multinational company engaged in the ddistribution, fitting, adaptation and personalization of hearing systems (hearing aids) designed to meet the needs of those suffering from hearing disabilities. Co. is also engaged in the sale of accessories such as batteries, consumables and spare parts, as well as in the distribution of biomedical devices. Co. is active in 20 different countries: Italy, France, Germany, Switzerland, The Netherlands, Belgium, Luxembourg, the U.K., Ireland, Spain, Portugal, Hungary, Turkey, the U.S., Canada, Australia, New Zealand, India, Egypt, and in Poland.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

ResearchPool Subscriptions

Get the most out of your insights

Get in touch